From rssfeeds@jmason.org  Thu Sep 26 16:42:34 2002
Return-Path: <rssfeeds@example.com>
Delivered-To: yyyy@localhost.example.com
Received: from localhost (jalapeno [127.0.0.1])
	by jmason.org (Postfix) with ESMTP id 1A9A116F17
	for <jm@localhost>; Thu, 26 Sep 2002 16:41:36 +0100 (IST)
Received: from jalapeno [127.0.0.1]
	by localhost with IMAP (fetchmail-5.9.0)
	for jm@localhost (single-drop); Thu, 26 Sep 2002 16:41:36 +0100 (IST)
Received: from dogma.slashnull.org (localhost [127.0.0.1]) by
    dogma.slashnull.org (8.11.6/8.11.6) with ESMTP id g8QFWAg25112 for
    <jm@jmason.org>; Thu, 26 Sep 2002 16:32:10 +0100
Message-Id: <200209261532.g8QFWAg25112@dogma.slashnull.org>
To: yyyy@example.com
From: newscientist <rssfeeds@example.com>
Subject: West Nile vaccine "in three years"
Date: Thu, 26 Sep 2002 15:32:10 -0000
Content-Type: text/plain; encoding=utf-8
X-Spam-Status: No, hits=0.0 required=5.0
	tests=AWL
	version=2.50-cvs
X-Spam-Level: 

URL: http://www.newsisfree.com/click/-3,8251867,1440/
Date: Not supplied

A genetically engineered yellow fever vaccine shows promise in animal tests - 
if fast-tracked it could soon be available for humans


